SEC Form 4 · accession 0001225208-17-012564
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B. Ullem
Officer — CVP, CFO
Period of report
Jul 10, 2017
Accepted (ET)
Jul 11, 2017 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 10, 2017 | F | 297 | $118.17 | D | 36,666 | D | |
| Common StockF1 | holding | — | — | — | 47,604 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person; and it reflects 271 shares that were previously reported as directly held but are currently held in trust.